Cross-Sector entity
Avanos Medical is most often covered alongside American Tower, which appears in 2 of these 3 stories. defense-tech accounts for 1 of the 3 tracked stories, while 2 other categories carry the remainder. Avanos Medical appears in 3 tracked Cross-Sector stories from February 26, 2026.
3 verified stories tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Avanos Medical is most often covered alongside American Tower, which appears in 2 of these 3 stories. defense-tech accounts for 1 of the 3 tracked stories, while 2 other categories carry the remainder. Avanos Medical appears in 3 tracked Cross-Sector stories from February 26, 2026. The tracked stories average 2.3 original sources each.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Avanos Medical. Shared-story counts are live from our verified record — not editorial picks.
Infrastructure Outlook
American Tower to navigate elevated churn in international footprints and carrier consolidation impacts.
Q4 2025 Earnings Call
Management discusses year-end results and provides guidance for the 2026 fiscal year.
Earnings Release
Both companies report Q4 results; Avanos highlights SNS strength while AMT notes DISH default.
Dividend Declaration
Board of Directors declares a $0.09 per share dividend, signaling financial stability.
MDA SHIELD Contract
Leonardo DRS awarded a position on the Missile Defense Agency's SHIELD IDIQ contract.
Tariff Mitigation Launch
Avanos begins implementing operational efficiency plans to counter potential trade cost increases.
Fiscal Year End
Avanos and American Tower conclude their 2025 fiscal years with strong performance in core segments.
Avanos Medical (AVNS) reported a strong 2025 finish with sales exceeding revised targets, driven by its Specialty Nutrition Systems segment. In contrast, American Tower (AMT) faces a challenging 2026 outlook due to a payment default by DISH and increased international churn.
Avanos Medical reported Q4 2025 earnings at the high end of guidance, driven by robust performance in its Specialty Nutrition Systems segment. Meanwhile, infrastructure provider American Tower highlighted durable data center demand despite facing headwinds from carrier defaults.
Source: Markets Daily · The Lincolnian Online
Leonardo DRS reported strong Q4 2025 performance, bolstered by critical wins in missile defense and a steady expansion of its naval propulsion business. The company's declaration of a $0.09 dividend reflects growing confidence in its long-term role within the U.S. Navy's submarine modernization programs.
Source: finance.yahoo.com · finance.yahoo.com
